As medical professionals, it's important to stay informed about uncommon conditions that may affect our patients. Legg-Calve-Perthes Disease is one such condition that primarily affects children between the ages of 4 and 10 years old. It occurs when blood supply to the femoral head (top part of the thigh bone) is disrupted, causing a degeneration of bone tissue and eventual collapse. In this blog post, we'll explore the causes and symptoms of Legg-Calve-Perthes Disease so that you can better diagnose and treat your patients with this challenging condition.
The exact cause of Legg-Calve-Perthes Disease remains unknown. However, it is believed that a disruption in blood flow to the femoral head may be the primary trigger for the condition. Some experts believe that a genetic predisposition may also play a role.
Other risk factors include age; children between 4 and 10 years old are most commonly affected by this disease. Boys are more likely than girls to develop Legg-Calve-Perthes Disease, with the ratio being approximately four boys affected for every one girl.
Certain medical conditions such as sickle cell disease or clotting disorders can increase the risk of developing this condition. It's worth noting that some medications like steroids have been known to contribute towards Legg-Calve-Perthes Disease development.
While there is no definitive answer on what causes Legg-Calve-Perthes Disease, understanding potential risk factors can help you diagnose and treat patients who present with this challenging condition more effectively.
Legg-Calve-Perthes disease, also known as Perthes disease or avascular necrosis of the femoral head, is a condition that affects children between 4 to 10 years old. The disorder causes inadequate blood flow to the hip joint, leading to bone death and eventual collapse of the ball-shaped part of the hip joint.
The early symptoms of Legg-Calve-Perthes disease may include limping, stiffness in the hip or knee area, and mild pain in the groin or thigh region. These signs may worsen over time as more damage occurs within the affected area.
As Legg-Calve-Perthes progresses, it can lead to reduced mobility and muscle strength in one leg compared to the other. Children may experience difficulty with physical activities such as running or jumping due to limited range of motion caused by pain and stiffness.
There are a variety of treatment options available for Legg-Calve-Perthes Disease, depending on the severity and stage of the condition. The goal of treatment is to relieve pain, improve mobility and prevent deformity in the hip joint.
For more advanced cases, non-surgical interventions such as physical therapy or bracing may be recommended. Physical therapy helps strengthen muscles around the hip joint while bracing provides support to keep the femoral head in place during movement.
In severe cases where there is significant damage to the hip joint, surgery may be required. Surgical options include osteotomy (reshaping of bone), arthroscopy (minimally invasive surgery) and in extreme cases total hip replacement.
Legg-Calve-Perthes disease is a condition that affects the hip joint in children. The cause of the disease is not yet fully understood, but it's believed that factors such as genetics and blood flow to the hip may play a role.
The symptoms of Legg-Calve-Perthes disease can range from mild pain and stiffness to severe disability. Early diagnosis and treatment are crucial for preventing complications like arthritis.
Fortunately, there are several treatment options available for children with Legg-Calve-Perthes disease including non-surgical approaches like physical therapy, bracing and medication as well as surgery in some cases.
1.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
2.
Formaldehyde releasers found in common personal care products used especially by Black and Latina women
3.
Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer
4.
'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link
5.
GLP-1 Receptor antagonists used in a study allay fears about thyroid cancer.
1.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
2.
Exploring the Mysteries of Myxoma: A New Frontier in Medical Research
3.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
4.
Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide
5.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Navigating the Complexities of Ph Negative ALL - Part X
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation